Description
Our objective is to examine “coverage, price, and reimbursement” (“CPR”) for multigene tests broadly and for cancer-related indications, specifically, why tests are covered/not covered by payers, how this is changing over time, and how CPR influences testing decisions and practices in clinic settings.
Prime PI is Kathryn A. Phillips, Ph.D., UCSF. Site PI is Su-Ying Liang, Ph.D.
Principal Investigator
Funder
National Institutes of Health - National Cancer Institute
Start Date
July 01, 2018
End Date
June 30, 2021
Research Topics
Related Studies
Breast Cancer Chemoprevention in Primary Care at Geisinger
Investigators: Xiaowei (Sherry) Yan, PhD, MS, External PI, Principal Investigator
COVID-19 Impacts on Cancer Care Management, Patient Experience and Care Costs
Investigators: Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D., Cheryl Stults, Ph.D.
Cancer Liquid Biopsy Monitoring Study
Investigators: Gregory J. Tranah, Ph.D., Mohammed Kashani-Sabet, M.D., Deepti Behl, MD
Impact of COVID-19 on Cancer Care Management
Investigators: Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D.
Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizations Contexts
Investigators: External PI, Principal Investigator, Su-Ying Liang, Ph.D., Monique de Bruin, M.D., MPH
Improving Cancer Care
Investigators: Su-Ying Liang, Ph.D., Harold (Hal) Luft, Ph.D., Ellis C. Dillon, Ph.D.
Lung Cancer in Never Smokers: Incidence, Risk Factors and Molecular Characteristics in Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Women
Investigators: Harold (Hal) Luft, Ph.D., Su-Ying Liang, Ph.D., External PI, Principal Investigator
Multilevel Study of Lung Cancer Screening Guidelines Implementation (MUST)
Investigators: Jiang Li, Ph.D., MPH, Dorothy Hung, Ph.D., M.A., MPH
Stupski Serious Illness Program Evaluation
Investigators: Ellis C. Dillon, Ph.D., Sylvia Sudat, PhD